GlassScriptPhysician profile
David Hoadley Ellison
NPI 1346337391
$11,934.53
in general payments reported to CMS, 2019-2025
4 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $235 · 2023: $11K · 2024: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $1,348 · Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,075.00 |
| Travel and Lodging | $1,347.66 |
| Food and Beverage | $276.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11,466.19 | 2023 | |
| Abbott Laboratories | $260.65 | 2022-2023 | Mitraclip |
| Boston Scientific Corporation | $133.51 | 2024 | |
| Ancora Heart, INC. | $74.18 | 2024 | Accucinch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ellison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.